While semaglutide will remain under patent in many regions until the early 2030s, the first generic versions are expected to launch in India imminently, with additional market entries anticipated in China, Canada, Brazil, Turkey, and South Africa in the months that follow
How does Tirzepatide Work In addition to its glucose-lowering effects, tirzepatide has been associated with significant weight loss in clinical trials
Participants also saw significant improvements in blood pressure, cholesterol, and insulin resistance
This combination has been explored in sports medicine for its potential to accelerate recovery from injuries, enhance flexibility, and minimize scar tissue formation
Daily use is actually recommended to maintain results from a dermatological standpoint
References: National Institutes of Health, Office of Dietary Supplements